OsteoporosisPsychoticReactionRisedronateAs women age and enter menopause, they are sometimes more susceptible than men to certain physical and mental disorders such as osteoporosis and late-onset schizophrenia. Risedronate (Actonel漏) is a bisphosphonate used for the treatment of osteopenia. Early ...
Researchprogressofgrowthhormoneinthetreatmentosteoporosissenile 系统标签: 中老年生长激素骨质osteoporosissenile男性 ・综述・ 基金项目:安徽省科技计划项目(编号10021403081) 倡通讯作者:**梅,Email:kangdongmei2006@sina.com 生长激素治疗中老年男性骨质疏松的研究进展 李保山 康冬梅 倡 安徽医科大学附属省立医院老年内...
FJ Thomson,EA Masson,AJM Boulton - 《Diabetic Medicine A Journal of the British Diabetic Association》 被引量: 17发表: 2010年 Osteoporosis in men: the role of testosterone and other sex-related factors Purpose of review: This review focuses on the role of testosterone in men on maximizing bon...
Targeting osteoblast may be the means of effectively improving both bone quality and mass, thus offering an intriguing alternative in the treatment of osteoporosis. Aside from injectable parathyroid hormone (PTH) and its novel preparations, PTH-related peptide (PTHrP), calcilytics, beta-adrenergic rec...
In 1998, the first Japanese practice guidelines on osteoporosis was published. It has been updated several times, with the most recent being the full-scale
(ndings)isfrequentlyusedinstagingONFH.Astagingandclassi,cationsystemwasproposedbyChinesescholarsinrecentyears.Themajordifferentialdiagnosesincludemid−latetermosteoarthritis,transientosteoporosis,andsub-chondralinsuf,ciencyfracture.ManagementalternativesforONFHconsistofnon-operativetreatmentandoperativetreatment.Core...
Adult b... F Cosman - 《Medgenmed》 被引量: 42发表: 2005年 Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis, 2006 On the basis of these considerations, the Clinical Guidelines Committee of Osteoporosis Canada suggests the following recommendations ...
Clinical Interventions in Aging Dovepress open access to scientific and medical research Open Access Full Text Article Selective estrogen receptor modulator review (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene Luigi Gennari Daniela Merlotti Ranuccio Nuti Department...
Secondary benefits of these changes of body composition in strength, muscle function, and metabolic and cardiovascular dysfunction are suggested by available data but require confirmation by large-scale studies. Recommendation 6: Bone density and fracture rate Osteopenia, osteoporosis, and fracture ...
of both persistent disease (AD developed in childhood with a chronic relapsing course until adulthood) and adult-onset disease (AD directly started later in life, i.e., after 18 years of age) is increased over time along with an increase in the incidence of childhood AD [3,4,5,6]. ...